8-Methoxypsoralen (Oxsoralen^®)

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Ampoules 0.02 mg/ml (5 ml) Available
Ampoules	0.02 mg/ml (5 ml)	Available
Indicazioni: Linfoma Cutaneo a cellule T (CTCL)

Acetylsalicylsäure (ASS)

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Gastro-resistant tablets 75 mg Available
Gastro-resistant tablets	75 mg	Available
Gastro-resistant tablets 100 mg Available
Gastro-resistant tablets	100 mg	Available
Gastro-resistant tablets 160 mg Available
Gastro-resistant tablets	160 mg	Available
Tablets 75 mg Available
Tablets	75 mg	Available
Tablets 100 mg Available
Tablets	100 mg	Available
Indicazioni: Antithrombotika

Benfotiamine

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Film-coated tablets 50 mg Available
Film-coated tablets	50 mg	Available
Film-coated tablets 150 mg Available
Film-coated tablets	150 mg	Available
Film-coated tablets 300 mg Available
Film-coated tablets	300 mg	Available
Indicazioni: Vitamin B1 Deficiency

Brivaracetam

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Film-coated tablets 10 mg Available in Q1 2024
Film-coated tablets	10 mg	Available in Q1 2024
Film-coated tablets 25 mg Available in Q1 2024
Film-coated tablets	25 mg	Available in Q1 2024
Film-coated tablets 50 mg Available in Q1 2024
Film-coated tablets	50 mg	Available in Q1 2024
Film-coated tablets 75 mg Available in Q1 2024
Film-coated tablets	75 mg	Available in Q1 2024
Film-coated tablets 100 mg Available in Q1 2024
Film-coated tablets	100 mg	Available in Q1 2024
Indicazioni: Epilepsy

Buprenorphine

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Compresse sublinguali 0.2 mg Available
Compresse sublinguali	0.2 mg	Available
Compresse sublinguali 0.4 mg Available
Compresse sublinguali	0.4 mg	Available
Compresse sublinguali 1 mg Available
Compresse sublinguali	1 mg	Available
Compresse sublinguali 2 mg Available
Compresse sublinguali	2 mg	Available
Compresse sublinguali 4 mg Available
Compresse sublinguali	4 mg	Available
Compresse sublinguali 6 mg Available
Compresse sublinguali	6 mg	Available
Compresse sublinguali 8 mg Available
Compresse sublinguali	8 mg	Available
Compresse sublinguali 12 mg Available
Compresse sublinguali	12 mg	Available
Compresse sublinguali 16 mg Available
Compresse sublinguali	16 mg	Available
Indicazioni: Opioid Use Disorder

Buprenorphine + Naloxone

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Compresse sublinguali 2 mg+0.5 mg Available
Compresse sublinguali	2 mg+0.5 mg	Available
Compresse sublinguali 4 mg+1 mg Available
Compresse sublinguali	4 mg+1 mg	Available
Compresse sublinguali 8 mg+2 mg Available
Compresse sublinguali	8 mg+2 mg	Available
Compresse sublinguali 1 mg+0.25 mg Available in Q4 2023
Compresse sublinguali	1 mg+0.25 mg	Available in Q4 2023
Compresse sublinguali 12 mg+3 mg Available in Q4 2023
Compresse sublinguali	12 mg+3 mg	Available in Q4 2023
Compresse sublinguali 16 mg+4 mg Available in Q4 2023
Compresse sublinguali	16 mg+4 mg	Available in Q4 2023
Indicazioni: Opioid Use Disorder

Candesartan + Chlortalidone

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Tablets 8 mg+12.5 mg Available in 2024
Tablets	8 mg+12.5 mg	Available in 2024
Tablets 16 mg+12.5 mg Available in 2024
Tablets	16 mg+12.5 mg	Available in 2024
Tablets 32 mg+12.5 mg Available in 2024
Tablets	32 mg+12.5 mg	Available in 2024
Tablets 32 mg+25 mg Available in 2024
Tablets	32 mg+25 mg	Available in 2024
Indicazioni: High Blood Pressure

Esketamine

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Solution for injection or infusion 5 mg/ml (2 ml, 5 ml, 10 ml) Available
Solution for injection or infusion	5 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 25 mg/ml (2 ml, 5 ml, 10 ml) Available
Solution for injection or infusion	25 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 5 mg/ml (5 ml, 10 ml, 20 ml) Available
Solution for injection or infusion	5 mg/ml (5 ml, 10 ml, 20 ml)	Available
Solution for injection or infusion 25 mg/ml (5 ml, 10 ml, 20 ml) Available
Solution for injection or infusion	25 mg/ml (5 ml, 10 ml, 20 ml)	Available
Indicazioni: Narcotic, Severe Pain

Eslicarbazepine

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Tablets 200 mg Available
Tablets	200 mg	Available
Tablets 400 mg Available
Tablets	400 mg	Available
Tablets 600 mg Available
Tablets	600 mg	Available
Tablets 800 mg Available
Tablets	800 mg	Available
Indicazioni: Epilepsy

Eszopiclone

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Film-coated tablets 1 mg Available
Film-coated tablets	1 mg	Available
Film-coated tablets 2 mg Available
Film-coated tablets	2 mg	Available
Film-coated tablets 3 mg Available
Film-coated tablets	3 mg	Available
Indicazioni: Insomnia

Ethosuximide

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Syrup 50 mg/ml (250 ml) Available
Syrup	50 mg/ml (250 ml)	Available
Indicazioni: Epilepsy

Fe²⁺ + Ascorbic Acid (Ferretab^®)

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Capsules 100 mg+20 mg Dossier update pending
Capsules	100 mg+20 mg	Dossier update pending
Indicazioni: Anaemia

Fe²⁺ + Ascorbic Acid+ Folic Acid (Ferretab^® comp plus)

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Capsules 66.7 mg+100 mg+0.8 mg Available
Capsules	66.7 mg+100 mg+0.8 mg	Available
Indicazioni: Anaemia during Pregnancy

Fe²⁺ + Folic Acid (Ferretab^® comp)

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Capsules 50 mg+0.5 mg Dossier update pending
Capsules	50 mg+0.5 mg	Dossier update pending
Indicazioni: Anaemia during Pregnancy

Fluoxetine

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Film-coated tablets 20 mg Available
Film-coated tablets	20 mg	Available
Film-coated tablets 40 mg Available
Film-coated tablets	40 mg	Available
Indicazioni: Depression

Folic Acid

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Tablets 1 mg Available
Tablets	1 mg	Available
Tablets 5 mg Available
Tablets	5 mg	Available
Indicazioni: Folic Acid Deficiency

Hydromorphone

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Solution for injection 2 mg/ml (1 ml) Available
Solution for injection	2 mg/ml (1 ml)	Available
Solution for injection 10 mg/ml (1 ml, 10 ml) Available
Solution for injection	10 mg/ml (1 ml, 10 ml)	Available
Solution for injection 20 mg/ml (1 ml) Available
Solution for injection	20 mg/ml (1 ml)	Available
Solution for injection 50 mg/ml (1 ml) Available
Solution for injection	50 mg/ml (1 ml)	Available
Film-coated tablets 1.3 mg Available in Q3 2023
Film-coated tablets	1.3 mg	Available in Q3 2023
Film-coated tablets 2.6 mg Available in Q3 2023
Film-coated tablets	2.6 mg	Available in Q3 2023
Indicazioni: Severe Pain

Hydroxocobalamine

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Solution for injection 1 mg/ml (1 ml) Available
Solution for injection	1 mg/ml (1 ml)	Available
Indicazioni: Vitamin B12 Deficiency

Ketamine

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Solution for injection or infusion 10 mg/ml (2 ml, 5 ml, 10 ml) Available
Solution for injection or infusion	10 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 50 mg/ml (2 ml, 5 ml, 10 ml) Available
Solution for injection or infusion	50 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 10 mg/ml (5 ml, 10 ml, 20 ml) Available
Solution for injection or infusion	10 mg/ml (5 ml, 10 ml, 20 ml)	Available
Solution for injection or infusion 50 mg/ml (5 ml, 10 ml, 20 ml) Available
Solution for injection or infusion	50 mg/ml (5 ml, 10 ml, 20 ml)	Available
Indicazioni: Narcotic, Severe Pain

Lacosamide

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Film-coated tablets 50 mg Available
Film-coated tablets	50 mg	Available
Film-coated tablets 100 mg Available
Film-coated tablets	100 mg	Available
Film-coated tablets 150 mg Available
Film-coated tablets	150 mg	Available
Film-coated tablets 200 mg Available
Film-coated tablets	200 mg	Available
Oral solution 10 mg/ml (200 ml, 500 ml) Available
Oral solution	10 mg/ml (200 ml, 500 ml)	Available
Solution for infusion 10 mg/ml (10 ml, 20 ml) Available
Solution for infusion	10 mg/ml (10 ml, 20 ml)	Available
Solution for infusion 10 mg/ml (20 ml) Available
Solution for infusion	10 mg/ml (20 ml)	Available
Indicazioni: Epilepsy

Levetiracetam

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Oral solution 100 mg/ml (150 ml, 300 ml) Available
Oral solution	100 mg/ml (150 ml, 300 ml)	Available
Concentration for solution for infusion 100 mg/ml (5 ml) Available
Concentration for solution for infusion	100 mg/ml (5 ml)	Available
Indicazioni: Epilepsy

Levomethadone

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Tablets 2.5 mg Available
Tablets	2.5 mg	Available
Tablets 5 mg Available
Tablets	5 mg	Available
Tablets 10 mg Available
Tablets	10 mg	Available
Tablets 20 mg Available
Tablets	20 mg	Available
Tablets 30 mg Available
Tablets	30 mg	Available
Concentration for oral solution 5 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000ml) Available
Concentration for oral solution	5 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000ml)	Available
Indicazioni: Opioid Use Disorder

Metamizole

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Solution for injection 500 mg/ml (2 ml, 5 ml) Available
Solution for injection	500 mg/ml (2 ml, 5 ml)	Available
Film-coated tablets 500 mg Available in 2024
Film-coated tablets	500 mg	Available in 2024
Film-coated tablets 1000 mg Available in 2024
Film-coated tablets	1000 mg	Available in 2024
Indicazioni: Mild to Moderate Pain

Methadone

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Tablets 5 mg Available
Tablets	5 mg	Available
Tablets 10 mg Available
Tablets	10 mg	Available
Tablets 20 mg Available
Tablets	20 mg	Available
Tablets 40 mg Available
Tablets	40 mg	Available
Tablets 60 mg Available
Tablets	60 mg	Available
Concentration for oral solution 10 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000 ml) Available
Concentration for oral solution	10 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000 ml)	Available
Indicazioni: Opioid Use Disorder

Metoclopramide

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Oral solution 1 mg/ml (150 ml) Available
Oral solution	1 mg/ml (150 ml)	Available
Solution for injection or infusion 5 mg/ml (2 ml, 10 ml) Available
Solution for injection or infusion	5 mg/ml (2 ml, 10 ml)	Available
Indicazioni: Emesis, Nausea

Morphine

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Solution for injection 10 mg/ml (1 ml) Available
Solution for injection	10 mg/ml (1 ml)	Available
Solution for injection 10 mg/ml (10 ml) Available
Solution for injection	10 mg/ml (10 ml)	Available
Solution for injection 20 mg/ml (10 ml) Available
Solution for injection	20 mg/ml (10 ml)	Available
Indicazioni: Severe Pain

Oxycodone

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Film-coated tablets 5 mg Available
Film-coated tablets	5 mg	Available
Film-coated tablets 10 mg Available
Film-coated tablets	10 mg	Available
Film-coated tablets 20 mg Available
Film-coated tablets	20 mg	Available
Prolonged-release tablets 5 mg Available
Prolonged-release tablets	5 mg	Available
Prolonged-release tablets 10 mg Available
Prolonged-release tablets	10 mg	Available
Prolonged-release tablets 15 mg Available
Prolonged-release tablets	15 mg	Available
Prolonged-release tablets 20 mg Available
Prolonged-release tablets	20 mg	Available
Prolonged-release tablets 30 mg Available
Prolonged-release tablets	30 mg	Available
Prolonged-release tablets 40 mg Available
Prolonged-release tablets	40 mg	Available
Prolonged-release tablets 60 mg Available
Prolonged-release tablets	60 mg	Available
Prolonged-release tablets 80 mg Available
Prolonged-release tablets	80 mg	Available
Oral solution 1 mg/ml (100 ml, 250 ml, 300 ml) Available
Oral solution	1 mg/ml (100 ml, 250 ml, 300 ml)	Available
Oral solution 10 mg/ml (30 ml, 100 ml, 120 ml) Available
Oral solution	10 mg/ml (30 ml, 100 ml, 120 ml)	Available
Solution for injection or infusion 10 mg/ml (1 ml, 2 ml) Available
Solution for injection or infusion	10 mg/ml (1 ml, 2 ml)	Available
Indicazioni: Severe Pain

Oxycodone + Naloxone

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Prolonged-release tablets 5 mg+2.5 mg Available
Prolonged-release tablets	5 mg+2.5 mg	Available
Prolonged-release tablets 10 mg+5 mg Available
Prolonged-release tablets	10 mg+5 mg	Available
Prolonged-release tablets 20 mg+10 mg Available
Prolonged-release tablets	20 mg+10 mg	Available
Prolonged-release tablets 30 mg+15 mg Available
Prolonged-release tablets	30 mg+15 mg	Available
Prolonged-release tablets 40 mg+20 mg Available
Prolonged-release tablets	40 mg+20 mg	Available
Indicazioni: Severe Pain

Perampanel

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Film-coated tablets 2 mg Available
Film-coated tablets	2 mg	Available
Film-coated tablets 4 mg Available
Film-coated tablets	4 mg	Available
Film-coated tablets 6 mg Available
Film-coated tablets	6 mg	Available
Film-coated tablets 8 mg Available
Film-coated tablets	8 mg	Available
Film-coated tablets 10 mg Available
Film-coated tablets	10 mg	Available
Film-coated tablets 12 mg Available
Film-coated tablets	12 mg	Available
Indicazioni: Epilepsy

Potassium Iodide

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Tablets 65 mg Available
Tablets	65 mg	Available
Indicazioni: Radiation Prophylaxis

Tapentadol

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Film-coated tablets 25 mg Available
Film-coated tablets	25 mg	Available
Film-coated tablets 50 mg Available
Film-coated tablets	50 mg	Available
Film-coated tablets 75 mg Available
Film-coated tablets	75 mg	Available
Film-coated tablets 100 mg Available
Film-coated tablets	100 mg	Available
Oral solution 20 mg/ml (100 ml, 200 ml) Available
Oral solution	20 mg/ml (100 ml, 200 ml)	Available
Prolonged-release tablets 25 mg Available
Prolonged-release tablets	25 mg	Available
Prolonged-release tablets 50 mg Available
Prolonged-release tablets	50 mg	Available
Prolonged-release tablets 100 mg Available
Prolonged-release tablets	100 mg	Available
Prolonged-release tablets 150 mg Available
Prolonged-release tablets	150 mg	Available
Prolonged-release tablets 200 mg Available
Prolonged-release tablets	200 mg	Available
Prolonged-release tablets 250 mg Available
Prolonged-release tablets	250 mg	Available
Indicazioni: Severe Pain

Tizanidine

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Tablets 2 mg Available
Tablets	2 mg	Available
Tablets 4 mg Available
Tablets	4 mg	Available
Tablets 6 mg Available
Tablets	6 mg	Available
Indicazioni: Muscle Spasms

Tramadol

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Solution for injection 50 mg/ml (2 ml) Dossier update pending
Solution for injection	50 mg/ml (2 ml)	Dossier update pending
Oral drops 100 mg/ml (10 ml, 30 ml, 50 ml) Dossier update pending
Oral drops	100 mg/ml (10 ml, 30 ml, 50 ml)	Dossier update pending
Indicazioni: Moderate to Severe Pain

Trazodone

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Oral solution 10 mg/ml (120 ml) Available
Oral solution	10 mg/ml (120 ml)	Available
Prolonged-release tablets 75 mg Available in 2025
Prolonged-release tablets	75 mg	Available in 2025
Prolonged-release tablets 150 mg Available in 2025
Prolonged-release tablets	150 mg	Available in 2025
Indicazioni: Depression

Valproic Acid/Sodium Valproate

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Oral solution 300 mg/ml (100 ml) Available
Oral solution	300 mg/ml (100 ml)	Available
Gastro-resistant soft capsules 150 mg Dossier update pending
Gastro-resistant soft capsules	150 mg	Dossier update pending
Gastro-resistant soft capsules 300 mg Dossier update pending
Gastro-resistant soft capsules	300 mg	Dossier update pending
Gastro-resistant soft capsules 500 mg Dossier update pending
Gastro-resistant soft capsules	500 mg	Dossier update pending
Syrup 50 mg/ml (100 ml) Dossier update pending
Syrup	50 mg/ml (100 ml)	Dossier update pending
Solution for injection 100 mg/ml (5 ml) Dossier update pending
Solution for injection	100 mg/ml (5 ml)	Dossier update pending
Indicazioni: Epilepsy

Vitamin B1/B6 (B1=Benfotiamin)

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Film-coated tablets 100 mg+100 mg Available
Film-coated tablets	100 mg+100 mg	Available
Indicazioni: Vitamin B Deficiency

Vitamin B1/B6/B12

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Film-coated tablets 40 mg+90 mg+0,25 mg Available in Q3 2023
Film-coated tablets	40 mg+90 mg+0,25 mg	Available in Q3 2023
Hard capsules 40 mg+90 mg+0,25 mg Available in Q3 2023
Hard capsules	40 mg+90 mg+0,25 mg	Available in Q3 2023
Indicazioni: Vitamin B Deficiency

Vitamin B1/B6/B12 (Neuromultivit^®)

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Film-coated tablets 100 mg+200 mg+0.2 mg Dossier update pending
Film-coated tablets	100 mg+200 mg+0.2 mg	Dossier update pending
Solution for injection 50 mg+50 mg+0.5 mg/ml (2 ml) Dossier update pending
Solution for injection	50 mg+50 mg+0.5 mg/ml (2 ml)	Dossier update pending
Indicazioni: Neuropathic Pain, Vitamin B Deficiency

Vitamin D3

Formulazione	Dosaggio	Status	Forma farmaceutica
Formulazione / Dosaggio	Forma farmaceutica
Oral solution 14 400 IU/ml (12.5 ml, 30 ml) Available
Oral solution	14 400 IU/ml (12.5 ml, 30 ml)	Available
Oral solution 28 800 IU/ml (12.5 ml, 30 ml, 50 ml) Available
Oral solution	28 800 IU/ml (12.5 ml, 30 ml, 50 ml)	Available
Indicazioni: Vitamin D3 Deficiency

Licenze per i dossier

Domande?
Contattaci.

La Compagnia

Portafoglio

Collaborazioni

Servizi

Licenze per i dossier

Domande? Contattaci.

Domande?
Contattaci.